Oxfordshire Primary Care Commissioning Committee
|
|
- Trevor Hopkins
- 5 years ago
- Views:
Transcription
1 Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 6 March 2018 Paper No: 6 Title of Paper: Prescribing Incentive Scheme Proposal Paper is for: (please delete tick as appropriate) Discussion Decision Information Purpose and Executive Summary: The attached paper is being presented to OCCG executive on 27 February 2018 to gain feedback on the proposed Prescribing Incentive scheme. However due to the timing of OPCCC it has not been possible to update the paper following OCCG Executive and instead feedback will be provide verbally. The paper describes the four proposed elements of the scheme. To note: the following abbreviations have been used in the paper YTD year to date QP quality premium UTI urinary tract infection AKI acute kidney injury EPACT2 electronic prescribing and cost IRT integrated respiratory team COPD chronic obstructive pulmonary disease BB beta blockers STAR PU - Specific Therapeutic group Age-sex Related Prescribing Units DAMN diuretics/acei/arbs/metformin/nsaids ACEi angiotensin converting enzyme inhibitors ARB angiotensin II receptor blockers NSAIDs non steroidal anti-inflammatory drugs Financial Implications of Paper: The maximum county payment for the scheme will be approximately 600k which will be offset by savings on the prescribing budget. For it is expected that the maximum payment will be 0.80/patient/practice assuming all elements are achieved based on January 2109 practice list size The views of the Director of Finance will be reflected in the feedback from OCCG Executive. Action Required: The OPCCC is asked: Page 1 of 7
2 to consider the proposed Prescribing Incentive Scheme for approve for use in OCCG Priorities Supported (please delete tick as appropriate) Operational Delivery Transforming Health and Care Devolution and Integration Empowering Patients Engaging Communities System Leadership Equality Analysis Outcome: The proposed model of prescribing budget setting will take into account deprivation Link to Risk: AF26 Delivery of Primary Care Services, Lead Pharmacist for Medicines Optimisation Clinical / Executive Lead: Diane Hedges, Chief Operating Officer Date of Paper: February 2018 Page 2 of 7
3 Prescribing Incentive Scheme, Proposal Oxfordshire Clinical Commissioning Group 1.0 Aim To outline the proposed OCCG Prescribing Incentive Scheme, , for consideration and seek support from OCCG Executive. Key points The prescribing incentive scheme is designed to increase value for money by improving the quality and cost effectiveness of primary care prescribing. For a number of years the use of the incentive scheme has proved an effective way of incentivising practices to make efficiencies to realise benefits for patient care scheme is designed to align with key priorities. The scheme offers maximum achievable payment of 0.80 per patient A national Prescqipp budget setting model (appendix 1) provides greater confidence in realistic and achievable budgets. The introduction of epact2 and EMIS Enterprise Search and Report provide greater opportunity to identify meaningful priorities and monitor more accurately Potential savings areas are currently being finalised to offer priority options for practice work and aid budget achievement (element 1). These will be available in the annual OCCG Prescribing Report which will be discussed at practice meetings 2.0 Background 2.1 Prescribing Incentive Schemes have been successfully implemented in Oxfordshire for many years. Their purpose is to encourage and reward medicines optimisation, cost-effective and high quality prescribing. Success of previous schemes has resulted in reliable savings for OCCG and underspend against the overall primary care prescribing budget. The scheme has also led to closer working relationships between OCCG and GP practices resulting in high levels of overall engagement. Achievement of the scheme provides practice funds to directly benefit patients. 2.2 Oxfordshire compares well nationally with respect to cost-effective primary care prescribing. Based on the most recent epact data (November 2017) Oxfordshire cost per ASTRO-PU* is 2.97 YTD. This places Oxfordshire in the best 10% nationally, while the mean is 3.56 (STP average 3.05). However consideration of the most recent 3 months data shows us below the 10% threshold and therefore there is a need to maintain, and further embed, our current level of success. 1
4 Oxfordshire number of items (prescriptions) per 1000 ASTRO-PU YTD is also lower than the national mean ( v 118) but falls short of the top 10% threshold (84). The STP average is This suggests further scope for improvement. (Benchmarking data sourced from PrescQipp February 2018.) * ASTRO-PUs are used to weight prescribing information to allow information users to compare prescribing in different practices based on individual practice populations. The weighting is applied based on the practice populations for age, sex and patients aged Conditions of practice participation in the scheme 3.1 Inclusion is automatic for all Oxfordshire practices in the scheme 3.2 Table 1 Conditions required for participation. Condition Detail Annual Prescribing Meeting with the CCG s Prescribing Advisors in the spring/summer 2018 Use of ScriptSwitch for all prescribers Discuss the priorities and opportunities at the practice for the year and agree an approach to scheme achievement. It is expected that all practice clinical staff and, ideally, local Community Pharmacists will be invited to this meeting. Demonstrate its use through switches being made. This is a useful tool for making cost savings in prescribing as well as informing prescribers about quality issues 4.0 Content and detail of Scheme 4.1 The scheme will run from 1 st April 2018 to 31 st March Practices are encouraged to work towards achievement of all four elements however payment will only be triggered if the practice achieve element 1 target at year end. If successful, payment will be made for all other element targets which are met (see tables 2 and 3). Elements 1 to 3 are strictly defined, but the Quality Prescribing element 4 offers a number of options to meet the needs and capacity of individual practices. 4.2 All reviews/work are required to be completed within the year and submission of audit results must be made to the Medicines Optimisation Team by 30th April Where available, audit templates provided by the Medicines Optimisation Team must be used to ensure consistency of approach. 4.3 It is proposed that the budget achievement element is considered to be set as a locality target. This will share the risk amongst the practices and encourage engagement across the locality. The use of the Prescqipp budget setting model offers greater confidence in accurate and fair budget allocation at practice level and should therefore reassure at locality level. 2
5 Table 2 Cost/waste savings elements Elements Target Costeffectiveness 1 Prescribing within spend must fall within the allocated practice/locality budget allocation budget Detail Use of national tool for budget setting (appendix 1) Proposal that this be at locality level. 2 Repeat Prescribing. It is estimated that up to 10% of all prescribed medicines are not used properly and medicines worth 4% of the national drug budget are disposed of annually. For OCCG, this could equate to 3.4M. Each practice to review their current repeat prescribing policy and update as needed (CCG to provide a template where required) Submit an audit review of a sample of patients (totaling 0.5% of the practice population) to check for good practice in handling repeat prescriptions At least two practice staff members (inc. one admin member and one prescriber) to attend a training event at the CCG (e-learning course available also) Practices will be invited to take part in a project to review repeat prescribing processes, the aim of which would be to reduce unnecessary waste in prescribing both in terms of actual medicines prescribed as well as the time spent in managing repeat prescriptions. As a result, it is anticipated that; patient care will be improved, by optimising medicines use, and time will be saved, as a result of reviewing and improving processes. The Medicines Optimisation Team will support practices in reviewing their repeat prescribing policies and processes including improving repeat prescribing in care homes (in line with NICE Guidelines on managing medicines in care homes). 3
6 Table 3 Quality elements Elements - Quality Target 3 Antibacterial Antimicrobial items per STAR PU to be below 0.52 (the Prescribing. Two parts OCCG average for Q3 and Q4 2016/17) PLUS high risk for which payment is antimicrobial items (cephalosporins, quinolones and coamoxiclav) as a % of all antimicrobial items to be < 10% achieved separately. These may require (in line with the national target). This target will be updating when QP measured using total figures for Q3 and Q4 (i.e. Oct is confirmed Mar 2019). Antimicrobial prescribing in UTI (In line with the Quality Premium 2018/19): Trimethoprim items prescribed to patients aged 70 or over: target a 30% (or greater) reduction compared with practice baseline Jan-Dec 16. This target will be measured using figures for Quality prescribing. Choice of one topic for audit as agreed at Annual Prescribing Meeting (alternative options available in annual prescribing report) Audit 0.5% of practice population (to be agreed) Reduction in opioid prescribing in non-end of life care Polypharmacy. epact2 dashboards indicate particular scope for improvement in meds likely to cause AKI (DAMN drug combinations) particularly over 65s. Heart failure. RightCare shows lower levels of ACE/ARB + BB prescribing v peer CCGs. NICE suggest readmission cost of 1.7k to 3.7k per patient Respiratory: COPD or asthma inhaler reviews. This supports development of OCCG IRT project. Detail In line with national policy and the Quality Premium, we are continuing to promote good antimicrobial stewardship and, therefore, include this element in the incentive scheme again. The aim will be to: improve the quality of antimicrobial prescribing through the promotion of self-care and management of minor infections, the use of back up prescriptions or no prescribing strategies, and education for both patients and clinicians reduce the incidence of Health Care Associated Infections (HCAIs) e.g. C.difficile by decreasing the prescribing of high risk, broad spectrum antibiotics e.g. cephalosporins, quinolones and co-amoxiclav reduce the incidence of E.Coli bacteraemia by reducing the prescribing of trimethoprim for urinary tract infections. Resources available to follow Audit of patients on 8+ meds using the Prescribing Rationalisation Clinical Tool and potentially also monitor any changes using epact 2 (i.e. average number of items) Prescqipp polypharmacy e-learning courses and bulletin available. Audit patients with heart failure and ensure dosage titration is optimised. pathway Review respiratory patients to optimise inhaler use, device and technique. In line with COPD / asthma guidance 4
7 Enablers 5.1 There are a number of resources and sources of support for practices. The CCG will provide all practices with an Annual Report of detailed prescribing information and data, identifying any areas where there may be potential savings or quality improvements. There will continue to be a dedicated scheme webpage providing resources; relevant protocols and audit templates, system searches, patient leaflets etc. The Prescribing Dashboard will be aligned to monitor scheme elements where appropriate, providing useful progress and benchmarking information. The CCG s Prescribing Advisers and wider Medicines Optimisation Team will support practice-based work on prescribing throughout the year. OCCG.medicines@nhs.net immediate access to Medicines Optimisation Team advice. Funding 6.1 The scheme will be funded through a top slice from the prescribing budget. 6.2 The scheme maximum payment level was set at 0.80 per patient. Current Oxfordshire population at January 2018 is 742,391 suggesting a maximum county payment of approximately 594k. However, Oxfordshire population continues to grow (+1.6% from April 2017 to January 2018), but not all practices achieve all elements and some practices fail to claim. Work continues to identify areas for potential savings which could be over 4m. Experience indicates that practice level work tends to release approximately a third of potential savings initiated. Other inyear projects, savings initiatives and opportunities will augment the annual savings potential further. Therefore there is continuing scope to further increase potential efficiencies, despite uncertainty of national pressures for next year. Continued incentive scheme opportunities also retain ongoing engagement of Oxfordshire prescribers with all medicines optimisation initiatives. 6.3 The prescribing budget allocation has yet to be confirmed. The GP practice element of the budget for was 84,682,783. Therefore the potential total payment to practices as outlined above would represent approximately 0.7% of the GP practice prescribing budget. Payment 7.1 The Medicines Optimisation Programme Board (appendix 2) will consider representations for exceptionality (evidence required), or other significant factors, from practices for achievement adjustments and will have the power to adjust payments due. The maximum payment available will be 0.80 per patient (using practice population at January 2019). 5
8 Table 4 Element 1: Prescribing within budget allocation Element 2: Repeat prescribing Element 3a: Antibacterial items per STAR PU PLUS % high risk antimicrobials Element 3b: Prescribing in UTI Element 4: Quality prescribing Total 0.20 (25%) per registered patient 0.20 (25%) per registered patient 0.10(12.5%) per registered patient 0.10 (12.5%) per registered patient 0.20 (25%) per registered patient 0.80 per registered patient Practice use of scheme payment 8.1 All payments received from the scheme must go into practice funds, and not to individuals, for the benefit of patients of the practice. 9.0 Conclusion 9.1 Oxfordshire incentive schemes have reliably delivered savings as well as encouraging wider engagement between practices and OCCG. The proposed scheme provides a number of elements to ensure all practices have fair opportunity to participate and achieve payment. The Medicines Optimisation Team provides a high level of resources and support to the scheme as well as the wider prescribing agenda. There remains scope for continued savings and cost avoidance despite considerable uncertainty due to national pressures OCCG Executive consideration of: Seek feedback on: Achievement gateway for budget achievement at locality level. The scheme format combining cost and quality elements The proposed maximum payment per patient under the scheme as Heather Motion Lead for Medicines Optimisation February
9 Appendix 1: Prescqipp Prescribing Budget Setting Tool This tool considers Historic spend Populations Cost based ASTRO-PU Care home patients Deprivation, /English_Indices_of_Deprivation_2015_-_Statistical_Release.pdf Prescribing needs allocation, Appendix 2: Medicines Optimisation Programme Board Membership The Medicines Optimisation Programme Board will comprise the following members: Clinical Lead for Medicines Optimisation (Chair) Head of Urgent Care and Medicines Optimisation Lead Pharmacists for Medicine Optimisation (3) Medicines Optimisation Pharmacists (3) Prescribing Analyst (vacancy currently supported by temporary dedicated Prescribing Adviser role) CCG Finance Lead CSU Management Accountant Programme Management Office representative as appropriate Declarations of interest are sought at the beginning of all meetings. Where conflicts of interest occur when the Board considers decisions regarding Prescribing Incentive Scheme achievement, the relevant Board member is excluded from the discussion and decision process. 7
NHS DORSET CLINICAL COMMISSIONING GROUP PRIMARY CARE COMMISSIONING COMMITTEE MEDICINES MANAGEMENT REPORT. The Committee is asked to note the report.
NHS DORSET CLINICAL COMMISSIONING GROUP 7.4 PRIMARY CARE COMMISSIONING COMMITTEE MEDICINES MANAGEMENT REPORT Date of the meeting 03/10/2018 Author Purpose of Report Recommendation Stakeholder Engagement
More informationMedicines and the kidney Community pharmacy s contribution to reducing harm associated with AKI
Medicines and the kidney Community pharmacy s contribution to reducing harm associated with AKI Annie Sellers, learning development pharmacist 1 Outline Who are CPPE? AKI learning campaign Audit on hydration
More informationTo Dip or Not To Dip
To Dip or Not To Dip a patient centred approach to improve the management of UTI in the Care Home environment FIS 30 th November 2017 #ToDipOrNotToDip #FIS17 Elizabeth Beech on behalf of colleagues National
More informationNew Care Models Pharmacy Services in Care Homes. Pauline Walton
New Care Models Pharmacy Services in Care Homes Pauline Walton East & North Hertfordshire Background By 2030 the number of older people with care needs is predicted to rise by 61% 2,000 extra carers needed
More informationWELSH AUDIT OFFICE REPORT ON PRIMARY CARE PRESCRIBING
AGENDA ITEM 2.5 28 January 2014 WELSH AUDIT OFFICE REPORT ON PRIMARY CARE PRESCRIBING Lead Responsibility: Medical Director Author: Clinical Board Pharmacist, Primary Community Intermediate Care Clinical
More informationDeveloping Plans for the Better Care Fund
Annex to the NHS England Planning Guidance Developing Plans for the Better Care Fund (formerly the Integration Transformation Fund) What is the Better Care Fund? 1. The Better Care Fund (previously referred
More informationPrimary Care Prescribing Cardiff and Vale University Health Board. Issued: December 2013 Document reference: 447A2013
Primary Care Prescribing Cardiff and Vale University Health Board Issued: December 2013 Document reference: 447A2013 Status of report This document has been prepared for the internal use of Cardiff and
More informationCCG authorisation: the role of medicines management
May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets
More informationClinical Pharmacists in General Practice March 2018
Clinical Pharmacists in General Practice March 2018 1. Background Following a successful national pilot programme, the General Practice Forward View committed over 100million to support an extra 1,500
More informationAlison Jamson, Head of Quality & Clinical Standards NHSMK&N Commissioning Support Hub
Enc 11/10f Subject: Meeting: NHSMK CQUIN Schemes MK Commissioning Board Date of Meeting: 13 December 2011 Report of: Alison Jamson, Head of Quality & Clinical Standards NHSMK&N Commissioning Support Hub
More informationBenchmark Data Sources
Medicare Shared Savings Program Quality Measure Benchmarks for the 2016 and 2017 Reporting Years Introduction This document describes methods for calculating the quality performance benchmarks for Accountable
More informationStrategic overview: NHS system
Strategic overview: NHS system Dr Keith Ridge, Chief Pharmaceutical Officer 1 November 2016 A collaborative approach Five Year Forward View Oct 2014 NHS planning guidance, Dec 2015: Every health and care
More informationQuality Framework Healthier, Happier, Longer
Quality Framework 2015-2016 Healthier, Happier, Longer Telford & Wrekin Clinical Commissioning Group (CCG) makes quality everyone s business. Our working processes are designed to ensure we all have the
More informationMedicines optimisation in care homes
Medicines optimisation in care homes Programme overview March 2018 NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops.
More information3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the March meeting were accepted as accurate.
South East London Area Prescribing Committee (APC) 23 June 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests, either
More informationNHS Innovation Accelerator. Implementation Toolkit. mycopd
NHS Innovation Accelerator Implementation Toolkit mycopd Introduction NHS England s Innovation and Technology Tariff (ITT) went live on 1 April 2017. This new Tariff was introduced to incentivise the adoption
More informationMedicines Use and Safety Annual Report The first stop for professional medicines advice. MUS Annual Report vs2 CL 1
Medicines Use and Safety Annual Report -17 The first stop for professional medicines advice www.sps.nhs.uk MUS Annual Report -17 vs2 CL 1 The Medicines Use and Safety (MUS) Team are part of the NHS Specialist
More informationPharmacists and GP surgeries
The Royal Pharmaceutical Society (RPS) believes that primary care patients should have the benefit of a pharmacist s clinical expertise similar to that currently experienced by patients in hospital Introduction
More informationThe safety of every patient we care for is our number one priority
HUMBER NHS FOUNDATION TRUST INFECTION PREVENTION AND CONTROL STRATEGY 2015-2017 1. Introduction Healthcare associated infections (HCAI) continue to be a major cause of patient harm and although nationally
More informationTo Dip or Not To Dip a patient centred approach to improve the management of UTIs in the Care Home environment
To Dip or Not To Dip a patient centred approach to improve the management of UTIs in the Care Home environment Sharing success AMS Workshop Leeds & London 2016 Elizabeth Beech Pharmacist - NHS Bath and
More informationCommunity Pharmacy in 2016/17 and beyond
Community Pharmacy in 2016/17 and beyond Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving that vision,
More informationKingston Primary Care commissioning strategy Kingston Medical Services
Kingston Primary Care commissioning strategy Kingston Medical Services Kathryn MacDermott Director of Planning and Primary Care Kathryn.macdermott@kingstonccg.nhs.uk kmacdermott@nhs.net 1 Contents 1. Introduction...
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationStage 2 GP longitudinal placement learning outcomes
Faculty of Life Sciences and Medicine Department of Primary Care & Public Health Sciences Stage 2 GP longitudinal placement learning outcomes Description This block focuses on how people and their health
More informationElectronic Prescribing and emar. Jonathan Sheldon Consultant Physician and Clinical Lead for Electronic patient records
Electronic Prescribing and emar Jonathan Sheldon Consultant Physician and Clinical Lead for Electronic patient records AIMS To discuss the support needed for the successful conclusion of this project To
More information5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework?
Item Number: 6.3 Governing Body Meeting: 4 February 2016 Report Sponsor Anthony Fitzgerald Director of Strategy and Delivery Report Author Anthony Fitzgerald Director of Strategy and Delivery 1. Title
More informationBEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING
BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING NON MEDICAL PRESCRIBING ADVISOR IMPLEMENTATION DATE: MAY 2009 REVIEW DATE: MAY 2010 Supplementary Prescribing The working definition of supplementary prescribing
More informationCluster Network Action Plan Neath Cluster. Abertawe Bro Morgannwg University Health Board Neath Cluster Action Plan
Cluster Network Action Plan 2016-17 Neath Cluster 1 Introduction The Neath Cluster Network includes a cluster of 8 GP practices, seven of the practices are engaged in GP training. The cluster network estate
More informationACHIEVING EXCELLENCE IN PHARMACEUTICAL CARE
ACHIEVING EXCELLENCE IN A STRATEGY FOR SCOTLAND IMPROVED AND INCREASED USE OF COMMUNITY PHARMACY SERVICES PHARMACY TEAMS INTEGRATED INTO GP PRACTICES TRANSFORMED HOSPITAL PHARMACY SERVICES THAT SUPPORTS
More informationCommissioning for Quality and Innovation (CQUIN) Schemes for 2015/16
Commissioning for Quality and Innovation (CQUIN) Schemes for 2015/16 Goal No. Indicator Name Contract 1 Acute Kidney Injury CWS CCG Contract - National CQUIN 2a Sepsis Screening CWS CCG Contract - National
More informationNHS Trafford Clinical Commissioning Group (CCG) Annual General Meeting(AGM) 26th September
RIGHT CARE RIGHT TIME RIGHT PLACE NHS Trafford Clinical Commissioning Group (CCG) Annual General Meeting(AGM) 26th September 2017 Introduction Matt Colledge Chair Introduction Trafford Clinical Commissioning
More informationWest Mid Beds Locality Development Plan
West Mid Beds Locality Development Plan 2013-14 Contents Introduction..3 1. Key Progress 2012/13.. 4 2. Locality Objectives 2013/14.5 2.1 Commissioning.5 2.2 Performance & Finance.. 9 2.3 Engagement 11
More informationPRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management
PRISM Collaborative: Transforming the Future of Pharmacy PeRformance Improvement for Safe Medication Management Mission: To improve the health of the people of Connecticut through safe and effective medication
More informationPrescribing Quality Review Scheme (PQRS) 2016/17
Introduction: The Prescribing Quality Review Scheme (PQRS) has been designed to reflect the four key principles of medicines optimisation: Understanding and improving patient experience. Evidence based
More informationImperial College Health Partners - at a glance
Imperial College Health Partners - at a glance Imperial College Health Partners - at a glance Our vision and purpose This document is intended to provide an introduction to Imperial College Health Partners
More informationLinking quality and outcome measures to payment for mental health
Linking quality and outcome measures to payment for mental health Technical guidance Published by NHS England and NHS Improvement 8 November 2016 Contents 1. Purpose of this document... 3 2. Context for
More informationPosition within the Organisation GP Research Lead
Document Description Document Type Standard Operating Procedure C-Reactive Protein (CRP) Testing Service Application General Practitioners, Version 1.0 Ratification date August 2016 Review date March 2018
More informationFinance and the NHS in Wales
Finance and the NHS in Wales This briefing provides an overview of Welsh NHS finance, the pressures on the system and the actions being taken by Local Health Boards and NHS Trusts in Wales to address them.
More informationAntimicrobial stewardship in Scotland: quality improvement agenda
Antimicrobial stewardship in Scotland: quality improvement agenda Dr Jacqueline Sneddon Project Lead Scottish Antimicrobial Prescribing Group Background Scottish Antimicrobial Prescribing Group (SAPG)
More informationDRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service
DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service Executive summary: The Cornwall Sustainability and Transformation Plan known as Shaping our Future will describe a new model of
More informationEvaluation of the Hywel Dda Community Pharmacist pilot optimising medicines treatment in heart failure.
Evaluation of the Hywel Dda Community Pharmacist pilot optimising medicines treatment in heart failure. Authors: Gareth Holyfield (Principal Pharmacist, Public Health Wales) Don Wilkes (Community Pharmacist,
More informationOperational Focus: Performance
Operational Focus: Performance Sandra Iskander Changes for 2015/16 Change of focus of 18-weeks and A&E 4-hour wait targets as recommended by Sir Bruce Keogh, Medical Director, NHS England. 18-weeks to
More informationMid Powys Cluster Plan
Mid Powys Cluster Plan 2016-17 The Cluster Network Development Domain with the Quality & Outcomes Framework supports medical practices to work collaboratively to: Understand local health needs and priorities
More informationHospital pharmacy and medicines optimisation. Supporting hospital pharmacy to improve patient outcomes
Hospital pharmacy and medicines optimisation Supporting hospital pharmacy to improve patient outcomes HOSP/0217 January 2017 Welcome About our learning We have developed this brochure for hospital pharmacy
More informationObesity - Tier 3 Weight Management Programme and Bariatric Surgery Criteria Based Access Protocol
NHS Dorset Clinical Commissioning Group Obesity - Tier 3 Weight Management Programme and Bariatric Surgery Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives 1. INTRODUCTION
More informationMental healthcare: to payment with. outcomes and risk. share components. Mental healthcare: capitated approach to. payment with.
Local payment examples examples Mental healthcare: Mental healthcare: a Capitated capitated approach approach to to payment with payment with outcomes and risk outcomes and risk share components share
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationCommissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016
Commissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016 Commissioning for Quality and Innovation (CQUIN) Introduction1 The CQUIN scheme is intended to deliver clinical
More informationNorth Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8
North Central London Medicines Optimisation Network Medicines Optimisation Committee Terms of Reference North Central London Medicines Optimisation Network 1 of 8 Document control Date Version Amendments
More informationSTRATEGIES TO ACHIEVE COST-EFFECTIVE PRESCRIBING
STRATEGIES TO ACHIEVE COST-EFFECTIVE PRESCRIBING Interim Guidance for Primary Care Trusts STRATEGIES TO ACHIEVE COST- EFFECTIVE PRESCRIBING: Interim Guidance for Primary Care Trusts Prepared by Colin Pearson
More informationClinical pharmacists in general practice links with community pharmacy
Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.
More informationNorfolk and Waveney STP - summary of key elements
Our Vision Norfolk and Waveney STP - summary of key elements 1. We have agreed our vision: To support more people to live independently at home, especially the frail elderly and those with long term conditions.
More informationWorkflow. Optimisation. hereweare.org.uk. hereweare.org.uk
Workflow Optimisation Dr. Paul Deffley & Jaivir Pall Clinical Lead & Commercial Lead About Here Not-for-profit social enterprise Membership organisation (our members are local GPs, Practice Managers, Practice
More informationUpdate Report to Clinical Members. Quarter 3; what have we done so far
Update Report to Clinical Members Quarter 3; what have we done so far Introduction: Dr Charlotte Canniff, Clinical Chair Following our Council of Members meeting in October we heard and recognised a clear
More informationHealthy London Partnership. Transforming London s health and care together
Healthy London Partnership Transforming London s health and care together London-wide transformation In 2014, two publications set out London s transformation priorities NHS Five Year Forward View Better
More informationA new integrated model for Care Homes from Walsall CCG/Healthcare NHS Trust
A new integrated model for Care Homes from Walsall CCG/Healthcare NHS Trust Sally Roberts - Director of Governance, Quality & Safety. Walsall CCG Katie Welborn Advanced Nurse Practitioner- Walsall Healthcare
More informationSouth East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions
South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,
More informationImprovement and Assessment Framework Q1 performance and six clinical priority areas
Governing Body 30 th September 2016 Improvement and Assessment Framework Q1 performance and six clinical priority areas Agenda item 16 Paper 10 Summariser: Authors and contributors: Executive Lead(s):
More informationApprove Ratify For Discussion For Information
NHS North Cumbria CCG Governing Body Agenda Item 2 August 2017 10 Title: General Practice Update Report August 2017 Purpose of the Report This is the first report on General Practice since the CCG boundary
More informationNHSGGC Respiratory Managed Clinical Network Annual Report 2010/11 Executive Summary and Table of Contents
NHSGGC Respiratory Managed Clinical Network Annual Report 2010/11 Executive Summary and Table of Contents The full report is available on the Respiratory MCN Website www.nhsggc.org.uk/respmcn 1. Executive
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationAdmission Avoidance (Rapid Response Team) Presenter: Karen Derrick Commissioning Manager Integrated Care team Camden Clinical Commissioning Group
Admission Avoidance (Rapid Response Team) Presenter: Karen Derrick Commissioning Manager Integrated Care team Camden Clinical Commissioning Group Admission Avoidance (Rapid Response Team) Background The
More informationImproving Quality of Care for Medicare Patients: Accountable Care Organizations
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Improving Quality of Care for Medicare Patients: FACT SHEET Overview http://www.cms.gov/sharedsavingsprogram On October
More informationMACRA and the Quality Payment Program. Frequently Asked Questions Edition
MACRA and the Quality Payment Program Frequently Asked Questions 2018 Edition What is MACRA?...3 What is the Quality Payment Program?...3 How do payments work under the QPP?...3 What is at risk under
More informationReview of Local Enhanced Services
Review of Local Enhanced Services 1. Background and context 1.1 CCGs are required to prepare for the phasing out of LESs by April 2014 by reviewing the existing LES portfolio and developing commissioning
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.28.09.2017/07 Title: Update on Winter resilience preparation 2017/18 Lead Director: Matthew Swindells, National Director: Operations and Information Purpose of Paper:
More informationOn behalf of COMMIT Team
Dr Rashmi Sharma & Dr Achyut Guleri On behalf of COMMIT Team Quality Safety People Delivery Environment Cost Consultant Microbiologist Clinical Director- Laboratory Medicine, Blackpool Teaching Hospitals
More informationReferral Management Programme Report to the CCG Board
Referral Management Programme Report to the CCG Board Emily O Donnell (Wandsworth CCG) 20 August 2015 Version 1. 22.8.2014 1 Executive Summary The Wandsworth CCG Referral Management Programme (RMP) aims
More informationRACGP Submission to Developing a National Antimicrobial Resistance Strategy for Australia
Submission to Developing a National Antimicrobial Resistance Strategy for Australia 5 November 2014 details Name of Organisation The Royal Australian College of General Practitioners () Postal Address
More informationHow Digital Systems Can Impact on Antimicrobial Stewardship (AMS) Stephen Hughes (Antimicrobial Pharmacist) Chelsea & Westminster Hospital
How Digital Systems Can Impact on Antimicrobial Stewardship (AMS) Stephen Hughes (Antimicrobial Pharmacist) Chelsea & Westminster Hospital Importance of AMS Antimicrobial Resistance: Any selective pressure
More informationCommissioning for quality and innovation (CQUIN): 2014/15 guidance. February 2014
Commissioning for quality and innovation (CQUIN): 2014/15 guidance February 2014 1 NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information Nursing Policy Commissioning
More informationQuality Improvement Plan (QIP) Narrative for Health Care Organizations in Ontario
Quality Improvement Plan (QIP) Narrative for Health Care Organizations in Ontario 2015-2016 3/31/2015 This document is intended to provide health care organizations in Ontario with guidance as to how they
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationGeneral Ward Driver Diagram and Change Package
General Ward Driver Diagram and Change Package The Institute for Healthcare Improvement A driver diagram is used to conceptualise an issue and to determine its system components which will then create
More informationWOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014
WOLVERHAMPTON CCG Governing Body Meeting ` Agenda item:12 TITLE OF REPORT: REPORT PRESENTED BY: Commissioning Committee Summary Dr Kamran Ahmed Title of Report: Update from the Commissioning Committee
More informationIntegrated respiratory action network for patients with COPD
Integrated respiratory action network for patients with COPD In this Future Hospital Programme case study Dr Helen Ward describes how a team from The Royal Wolverhampton NHS Trust established a respiratory
More informationSCHEDULE 2 THE SERVICES Service Specifications
SCHEDULE 2 THE SERVICES Service Specifications Service Specification No Service ParaDoc Commissioner City and Hackney CCG Commissioner Lead Leah Herridge Provider CHUHSE Provider Lead Date of Review September
More informationService Transformation Report. Resource and Performance
SUMMARY REPORT Meeting Date: 31 May 2018 Agenda Item: 9.1 Enclosure Number: 9 Meeting: Trust Board (Part 1) Title: Author: Accountable Director: Other meetings presented to or previously agreed at: Service
More informationPINCER in practice. Medicines Use And Safety Network Event. Gill Gookey. 25th June School of Medicine. Primary Care Pharmacist
School of Medicine PINCER in practice Medicines Use And Safety Network Event 25th June 2015 Gill Gookey Primary Care Pharmacist Rushcliffe CCG & University of Nottingham Plan for the presentation: Brief
More informationExecutive Summary points to consider by organisations providing Primary and Community Health services
pecialist Pharmacy ervice Medicines Use and afety A ummary of Pharmacy upport required to deliver Medicines Optimisation in Primary Care based and Community Health ervices: A guide for Organisational Boards
More informationPRIMARY CARE COMMISSIONING COMMITTEE
PRIMARY CARE COMMISSIONING COMMITTEE 1. Date of Meeting: 2. Title of Report: Western Avenue Medical Centre Personal Medical Services (PMS) Reinvestment Report 3. Key Messages: The Personal Medical Services
More informationNorthumberland, Tyne and Wear NHS Foundation Trust. Board of Directors Meeting. Meeting Date: 25 October Executive Lead: Rajesh Nadkarni
Agenda item 9 ii) Northumberland, Tyne and Wear NHS Foundation Trust Board of Directors Meeting Meeting Date: 25 October 2017 Title and Author of Paper: Clinical Effectiveness (CE) Strategy update Simon
More informationQuality Strategy
Governing Body Friday, 27 th May 2016 Quality Strategy 2016 2018 Agenda item 15 Paper 9 Author: Executive Lead: Relevant Committees or forums that have already reviewed this paper: Action required: Eileen
More informationGeneral Practice 5 Year Forward View Operational Plan Leicester, Leicestershire and Rutland (LLR) STP
Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group General Practice 5 Year Forward View Operational
More informationModels of community heart failure care pathways. Dr Jim Moore GP & GPSI Cardiology Cheltenham,GLOS
Models of community heart failure care pathways Dr Jim Moore GP & GPSI Cardiology Cheltenham,GLOS Declaration of Conflict of Interests Dr Jim Moore GP and GPwSI in Cardiology, Cheltenham NICE Guideline
More informationThe PCT Guide to Applying the 10 High Impact Changes
The PCT Guide to Applying the 10 High Impact Changes This Guide has been produced by the NHS Modernisation Agency. For further information on the Agency or the 10 High Impact Changes please visit www.modern.nhs.uk
More informationLondon Councils: Diabetes Integrated Care Research
London Councils: Diabetes Integrated Care Research SUMMARY REPORT Date: 13 th September 2011 In partnership with Contents 1 Introduction... 4 2 Opportunities within the context of health & social care
More informationMinutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager
Quality and Clinical Governance Committee Date Chair Minutes 18 July @ 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Members Present Gareth
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationCHF Readmission Initiative. Mary Fischer MSN, CCRN, PCCN, CHFN Cardiology Clinical Nurse Specialist St. Vincent Hospital Indianapolis, Indiana
CHF Readmission Initiative Mary Fischer MSN, CCRN, PCCN, CHFN Cardiology Clinical Nurse Specialist St. Vincent Hospital Indianapolis, Indiana St. Vincent 86 th Street Campus Heart Failure Program History
More informationMEDICINE SICK DAY RULES CARDS INTERIM EVALUATION
INTRODUCTION MEDICINE SICK DAY RULES CARDS INTERIM EVALUATION Report by: Clare Morrison, Lead Pharmacist (North), NHS Highland Dr Martin Wilson, Consultant Physician, Raigmore Hospital, NHS Highland Correspondence
More informationManaging Patients with Multiple Chronic Conditions
Best Practices Managing Patients with Multiple Chronic Conditions Arch Health Partners Case Study Organization Profile Palomar Pomerado Health, a public hospital system that includes 2 hospital campuses
More informationData Acquisition & Transmission
Using Clinically-Enhanced Claims Data to Guide Treatment of Acute Heart Failure An AHRQ Grant to MHA Data Acquisition & Transmission Pharmacy Data Overview of Data Acquisition Strategy Establish data specifications
More informationOur five year plan to improve health and wellbeing in Portsmouth
Our five year plan to improve health and wellbeing in Portsmouth Contents Page 3 Page 4 Page 5 A Message from Dr Jim Hogan Who we are What we do Page 6 Page 7 Page 10 Who we work with Why do we need a
More informationHard Truths Public Board 29th September, 2016
Hard Truths Public Board 29th September, 2016 Presented for: Presented by: Author Previous Committees Governance Professor Suzanne Hinchliffe CBE, Chief Nurse/Deputy Chief Executive Heather McClelland
More informationNHS standard contract letter templates for practice use
1 Use the hyperlinks to quickly reach each appendix. Appendix 1 Template response for missed appointment Letter to Trust requesting that the hospital liaises directly with a patient who has missed an outpatient
More informationPhysician Performance Analytics: A Key to Cost Savings
Physician Performance Analytics: A Key to Cost Savings Session #90, February 21, 2017 Jim Gera, SVP of Business Development, Signature Medical Group, Inc. 1 Speaker Introduction Jim Gera, MBA SVP of Business
More informationSutton Homes of Care Health forum newsletter: January 2016
Sutton Homes of Care Health forum newsletter: January 2016 Welcome to the latest edition of our care home forum newsletter, following our forum on 22 January 2016. Thank you to everyone who attended it
More informationPatient Led Repeat Prescription Ordering Pilot
Patient Led Repeat Prescription Ordering Pilot November 2016 March 2017 Project support by MLCSU Medicines Management and Optimisation Team Abigail Cowan MLCSU Project Lead Medicines Optimisation Pharmacist
More information